Sanders Morris Harris’s Minerva Neurosciences NERV Stock Holding History

Sanders Morris Harris’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,000	Closed	-$20K	–	303
2022 Q1	$20K	Buy	3,000 +1,500	+100%	+$9.2K	﹤0.01%	299
2021 Q4	$10K	Hold	1,500	–	–	﹤0.01%	336
2021 Q3	$17K	Hold	1,500	–	–	﹤0.01%	309
2021 Q2	$28K	Hold	1,500	–	–	0.01%	317
2021 Q1	$32K	Hold	1,500	–	–	0.01%	294
2020 Q4	$32K	Hold	1,500	–	–	0.01%	281
2020 Q3	$41K	Buy	+1,500	New	+$40.5K	0.01%	263

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Sanders Morris Harris's NERV Position: Q2 2022 in Review

Sanders Morris Harris sold out of Minerva Neurosciences (NERV) in Q2 2022, closing a stake of 3,000 shares — an estimated $20K sold.

Sanders Morris Harris first reported a position in NERV in Q3 2020 and held it in 7 quarters. The position peaked at $41K in Q3 2020. 23 funds tracked by Wall St. Rank hold NERV as of Q2 2022.

Sanders Morris Harris reported no remaining Minerva Neurosciences position as of Q2 2022 after selling out during the quarter.
Sanders Morris Harris sold 3,000 Minerva Neurosciences shares in Q2 2022, an estimated $20K.
Sanders Morris Harris first reported a position in Minerva Neurosciences in Q3 2020 and held it in 7 quarters.
Sanders Morris Harris's Minerva Neurosciences position peaked at $41K in Q3 2020.
23 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2022.

Based on Sanders Morris Harris's 13F filing for Q2 2022, filed 11 Jul 2022.